Attitudes and Perspectives of People Living With Human Immunodeficiency Virus: Findings From the Positive Perspectives Survey in Slovakia

被引:1
作者
Sojak, Lubomir [1 ]
Simekova, Katarina [2 ]
Piesecka, Lubica [3 ]
Wiesinger, Milos [4 ]
Jarcuska, Pavol [5 ,6 ]
机构
[1] Acad L Derers Univ Hosp, Dept Infectol & Geog Med, Ctr Treatment HIV AIDS Patients, Bratislava, Slovakia
[2] Univ Hosp, Dept Infectol & Travel Med, Ctr Management & Treatment HIV, Martin, TN, Slovakia
[3] Fac Hosp, Infectol Clin FSVaZ UKF, Nitra, Slovakia
[4] GlaxoSmithKline, Bratislava, Slovakia
[5] L Pasteur Univ Hosp, Dept Infectol & Travel Med, Ctr Management & Treatment HIV, Kosice, Slovakia
[6] Safarik Univ, Kosice, Slovakia
关键词
antiretroviral (ARV) therapy; discrimination; human immunodefeciency virus; patient perspectives; Slovakia; stigma; HIV; POLYPHARMACY;
D O I
10.3389/ijph.2021.642869
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives: To investigate the perspectives and attitudes of people living with human immunodeficiency virus (PLHIV) in Slovakia.Methods: A cross-sectional, computer-assisted web survey on health status, emotional support, stigmatisation, communication with physician, treatment, perception, decision-making, concerns, and treatment history. A representative sample of >10% of all PLHIV (N = 895) in Slovakia was invited to participate.Results: Mean age of the 117 respondents was 35.4 (+/- 8.9) years, 52.8% had higher education, and 67.0% were in full-time employment. Most (89.4%) were receiving antiretroviral therapy (ART), and 81.8% had undetectable viral load. Most (85.1%) were satisfied with their ART, and side effects were the primary reason for switching therapies. Most (60.8%) had informed only close friends or relatives about their HIV status, only 3 (2.9%) spoke openly about it, and 60.0% hid their ART from others. Of the 31 respondents (31.6%) who experienced stigmatisation, it was primarily from dentists and other physicians who refused to treat them.Conclusion: In general, PLHIV in Slovakia receive ART and are satisfied with it. They do not speak openly about their HIV status, and some have experienced discrimination.
引用
收藏
页数:12
相关论文
共 26 条
  • [1] Balogova L., 2020, 41 ANN SSVPL C
  • [2] Brondani MA, 2016, J CAN DENT ASSOC, V82
  • [3] Centers for Disease Control and Prevention, 2020, HIV STIGM DISCR
  • [4] de los Rios P., 2020, Popul Med, V2, P23, DOI [10.18332/popmed/124781, DOI 10.18332/POPMED/124781]
  • [5] The Next Therapeutic Challenge in HIV: Polypharmacy
    Edelman, E. Jennifer
    Gordon, Kirsha S.
    Glover, Janis
    McNicholl, Ian R.
    Fiellin, David A.
    Justice, Amy C.
    [J]. DRUGS & AGING, 2013, 30 (08) : 613 - 628
  • [6] European Centre for Disease Prevention and Control. HIV, 2020, AIDS SURV EUR 2020
  • [7] Ending the HIV-AIDS Pandemic - Follow the Science
    Fauci, Anthony S.
    Marston, Hilary D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (23) : 2197 - 2199
  • [8] Ending the Global HIV/AIDS Pandemic: The Critical Role of an HIV Vaccine
    Fauci, Anthony S.
    Folkers, Gregory K.
    Marston, Hilary D.
    [J]. CLINICAL INFECTIOUS DISEASES, 2014, 59 : S80 - S84
  • [9] Assessing quality of life in people with HIV in Spain: psychometric testing of the Spanish version of WHOQOL-HIV-BREF
    Fuster-RuizdeApodaca, Maria Jose
    Laguia, Ana
    Safreed-Harmon, Kelly
    Lazarus, Jeffrey V.
    Cenoz, Santiago
    del Amo, Julia
    [J]. HEALTH AND QUALITY OF LIFE OUTCOMES, 2019, 17 (01)
  • [10] Polypharmacy in the HIV-infected older adult population
    Gleason, Lauren J.
    Luque, Amneris E.
    Shah, Krupa
    [J]. CLINICAL INTERVENTIONS IN AGING, 2013, 8 : 749 - 763